title: [The EML4-ALK fusion gene in NSCLC and the clinical progress].
authors.affiliation: Department of Medical Oncology, Jilin Province Tumor Hospital, Changchun 130012, China.
authors.forename: Di
authors.initials: D
authors.lastname: Wu
authors.forename: Hong
authors.initials: H
authors.lastname: Yu
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D050939:Gene Fusion; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008869:Microtubule-Associated Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics*; D012697:Serine Endopeptidases / Q000235:genetics*
chemical_list: D018797:Cell Cycle Proteins; D008869:Microtubule-Associated Proteins; D047428:Protein Kinase Inhibitors; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases; C415585:EML4 protein, human; D012697:Serine Endopeptidases